Artículos por temáticas
En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.
FILTRAR POR:
Tema
159604 ARTíCULOS , VIENDO DEL 2011 AL 2025
Observational studies in Alzheimer disease: bridging preclinical studies and clinical trials
Brenowitz WD, Yaffe K.
Nat Rev Neurol. 2022 Dec;18(12):747-757. doi: 10.1038/s41582-022-00733-7. Epub 2022 Oct 31.
0
0
0
Dietary Nutrients and Prevention of Alzheimer's Disease
Chauhan PS, Yadav D, Arukha AP.
CNS Neurol Disord Drug Targets. 2022;21(3):217-227. doi: 10.2174/1871527320666210405141123.
0
0
0
Alzheimer's Disease: Key Insights from Two Decades of Clinical Trial Failures
Kim CK, Lee YR, Ong L, Gold M, Kalali A, Sarkar J.
J Alzheimers Dis. 2022;87(1):83-100. doi: 10.3233/JAD-215699.
0
0
0
Cognitive Stimulation in Moderate Alzheimer's Disease
Gonzalez-Moreno J, Satorres E, Soria-Urios G, Meléndez JC.
J Appl Gerontol. 2022 Aug;41(8):1934-1941. doi: 10.1177/07334648221089283. Epub 2022 May 27.
0
0
0
Combination Therapy in Alzheimer's Disease: Is It Time?
Salehipour A, Bagheri M, Sabahi M, Dolatshahi M, Boche D.
J Alzheimers Dis. 2022;87(4):1433-1449. doi: 10.3233/JAD-215680.
0
0
0
Health Disparities in Dementia
Balls-Berry JJE, Babulal GM.
Continuum (Minneap Minn). 2022 Jun 1;28(3):872-884. doi: 10.1212/CON.0000000000001088.
0
0
0
A Review of the Pathogenesis and Chinese Medicine Intervention of Alzheimer's Disease
Zhao J, Yang J, Ding L, Wang F, Lin L.
J Integr Neurosci. 2022 Nov 25;22(1):2. doi: 10.31083/j.jin2201002.
0
0
0
The Broad Range of Research in Alzheimer's Disease and Related Dementias
DeKosky ST, Duara R.
Neurotherapeutics. 2022 Jan;19(1):1-7. doi: 10.1007/s13311-022-01245-4. Epub 2022 May 13.
0
0
0
Amylin Pharmacology in Alzheimer's Disease Pathogenesis and Treatment
Corrigan RR, Piontkivska H, Casadesus G.
Curr Neuropharmacol. 2022;20(10):1894-1907. doi: 10.2174/1570159X19666211201093147.
0
0
0
Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease
Villegas C, Perez R, Petiz LL, Glaser T, Ulrich H, Paz C.
IUBMB Life. 2022 Aug;74(8):763-779. doi: 10.1002/iub.2613. Epub 2022 Apr 5.
0
0
0
Adenosine receptor signalling in Alzheimer's disease
Trinh PNH, Baltos JA, Hellyer SD, May LT, Gregory KJ.
Purinergic Signal. 2022 Sep;18(3):359-381. doi: 10.1007/s11302-022-09883-1. Epub 2022 Jul 23.
0
0
0
Vascular Considerations for Amyloid Immunotherapy
Foley KE, Wilcock DM.
Curr Neurol Neurosci Rep. 2022 Nov;22(11):709-719. doi: 10.1007/s11910-022-01235-1. Epub 2022 Oct 21.
0
0
0
Disease-Modifying Therapies for Alzheimer's Disease: More Questions than Answers
Golde TE.
Neurotherapeutics. 2022 Jan;19(1):209-227. doi: 10.1007/s13311-022-01201-2. Epub 2022 Feb 28.
0
0
0
Effects of Hypertension on Alzheimer's Disease and Related Disorders
Malone JE, Elkasaby MI, Lerner AJ.
Curr Hypertens Rep. 2022 Dec;24(12):615-625. doi: 10.1007/s11906-022-01221-5. Epub 2022 Sep 20.
0
0
0
Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress
Sang Z, Wang K, Dong J, Tang L.
Eur J Med Chem. 2022 Aug 5;238:114464. doi: 10.1016/j.ejmech.2022.114464. Epub 2022 May 20.
0
0
0
Comentarios
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:
En colaboración con:
